January 13, 2020
ISO9001:2015 Certification for our R&D and Clinical Activities in Oncology
Marseille, January 13, 2020 - Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and…
Read More
January 13-15, 2020
Biotech Showcase™ 2020
Biotech Showcase™ 2020 - San Francisco, California Investor conference We will be present during…
Read More
December 16, 2019
GNS561 to treat pancreas or colorectal cancer with liver metastasis
GENOSCIENCE PHARMA Announces Extension of GNS561 Phase 1/2 Clinical Trial to Patients with Pancreas or…
Read More
December 2, 2019
The GoforIsrael Investment Conference 2019
The GoforIsrael - Investment Conference 2019 - Tel Aviv, Israel We are honored to…
Read More
November 14, 2019
Outstanding Data on GNS561 in Combination with a PD-1 Inhibitor
Outstanding Data on GNS561 in Combination with a PD-1 Inhibitor to Be Presented at the…
Read More
September 25, 2019
Invest in the Future of Health Biotech, European Biotech Week
Invest in the Future of Health Biotech during the European Biotech Week 2019 (Brussels) …
Read More
November 8-12, 2019
The AASLD Liver Meeting 2019
The AASLD - Liver Meeting 2019 - Boston, Massachusetts, USA We have the pleasure…
Read More
October 16-18, 2019
GMP Symposium 2019
2019 GMP Symposium - Lyon, France DMPK-centred approach to predict Drug Efficacy and Safety …
Read More
October 2-5, 2019
85èmes Journées Scientifiques de l’AFEF 2019
85èmes Journées Scientifiques de l'AFEF 2019 - Marseille, France Genoscience Pharma will be present…
Read More
September 27 - October 1, 2019
ESMO Congress 2019
ESMO 2019 Congress - Barcelone, Spain Genoscience Pharma will be present during the ESMO…
Read More
